Innate Pharma SA (NASDAQ:IPHA)
| 3.73 Delayed Data As of 1:14pm ET |  -0.08 / -2.10%Today’s Change | 3.02 Today|||52-Week Range 11.95 | -18.20% Year-to-Date |
Latest IPHA News | Press Releases
No recent news for Innate Pharma SA.
Today’s Trading
| Previous close | 3.81 |
| Today’s open | 3.89 |
| Day’s range | 3.79 - 3.89 |
| Volume | 2,775 |
| Average volume (3 months) | 864,041 |
| Market cap | $362.5M |
Data as of 1:14pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -166.08% |
| Earnings growth (this year) | +36.81% |
| Earnings growth (next 5 years) | -22.50% |
| Revenue growth (last year) | -16.08% |
| P/E ratio | NM |
| Price/Sales | 4.98 |
| Price/Book | 1.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MEIPMEI Pharma Inc | -0.22 | -9.65% |
| CLLSCellectis SA | -0.11 | -1.67% |
| EYPTEyePoint Pharmaceuti... | -0.24 | -2.55% |
| LQDALiquidia Corp | -0.32 | -5.63% |
Data as of 4:00pm ET, 01/26/2022
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $64.8M |
| Annual profit (last year) | -$72.9M |
| Net profit margin | -112.58% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
